New federal initiatives to enhance the medical treatment of opioid dependence.
Opioid dependence is a chronic relapsing medical condition with substantial health and societal complications. Recent federal initiatives are designed to enhance the medical treatment of patients with opioid dependence and will expand the role of internists in the care of these patients. These initiatives include a process for federal exemptions to allow for pharmacologic treatment in office settings, waivers for the use of new medications, and new rules governing the oversight and distribution of opioid agonist medications for maintenance treatment. This perspective describes these initiatives and their implications for internists.
Fiellin
David A
DA
Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520-8025, USA. david.fiellin@yale.edu
O'Connor
Patrick G
PG
D000553:Ambulatory Care; D011307:Drug Prescriptions; D004502:Education, Medical, Continuing; D006078:Government Programs; D006801:Humans; D007880:Legislation, Drug; D009294:Narcotics / Q000819:agonists; D009293:Opioid-Related Disorders / Q000628:therapy*; D012106:Research; D014481:United States; D014486:United States Food and Drug Administration
D009294:Narcotics